In the April–June 2014 edition of Corporate Disputes, Group Vice President and Global Practice Leader Dr. Gregory Bell and other industry experts discuss pharma and biotech patent litigation.
CRA Sessions | Readily ascertainable? AI’s role in redefining trade secrets
Intellectual property expert and host David Duski (CRA) joins Brian Nolan (Mayer Brown), to explore the evolving intersection of AI and trade secret law.